EDIT:NASDAQ
Editas Medicine Inc
2,17 US$
arrow_upward
+1,40%(+0,030) 1K
13-noy, 16:00:01 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
2,14 US$
Yuqori
2,21 US$
Past
2,01 US$
Bozor kapitali
334,92 mln
Oʻrtacha hajm
2,42 mln
Hajmi
0,00
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,62 US$
Beta
2,09
Muomaladagi aksiyalar
154,34 mln
Xodimlar soni
87
Ochish
2,14 US$
Yuqori
2,21 US$
Past
2,01 US$
Bozor kapitali
334,92 mln
Oʻrtacha hajm
2,42 mln
Hajmi
0,00
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,62 US$
Beta
2,09
Muomaladagi aksiyalar
154,34 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Investing.com
·
38 daqiqa oldin
Morgan Stanley raises S&P 500 target on earnings growth, lower oil and AI adoption
MarketWatch
·
48 daqiqa oldin
Stock Market Today: Dow, S&P 500 and Nasdaq are set to fall as investors await Nvidia results and Anthropic's IPO this week: live updates
The Motley Fool
·
1 soat oldin
The S&P 500 Looks Cheaper Than It Has in Over 3 Years, but There’s a Catch
TradingView
·
2 soat oldin
Stock Market: Will S&P 500 Open Up or Down Today?
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida
CEO-
Xodimlar soni87
Asos solingannoy 2013
Bosh ofislar-
SektorHealth Care
Soha-
Veb-sayteditasmedicine.com